Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
Date
of
Report (Date of earliest event reported): March
19, 2008
|
BIOMETRX,
INC.
|
|
|
(Exact
name of registrant as specified in its
Charter)
|
|
Delaware
|
|
0-15807
|
|
31-1190725
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of
incorporation)
|
|
File
No.)
|
|
Identification
No.)
|
500
North Broadway, Suite 204, Jericho, New
York
|
|
11753
|
(Address
of principal executive
offices)
|
|
(Zip
Code)
|
|
(516)
937-2828
|
|
|
(Registrant’s
telephone number, including area
code)
|
|
|
|
|
|
N/A
|
|
|
(Former
Name or former address, if changed since
last report.)
|
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant
to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.24d-2(b)) |
o |
Pre-commencement communications pursuant
to
Rule 13e-4(c) under the Exchange Act (17 CFR
240.23e-4(c)) |
Item
1.01
Entry
Into a Material Definitive Agreement
On
March
19, 2008, BioMETRX, Inc. (the “Company”) announced in a press release that it
entered into a agreement with Biometric Investors, LLC. (“BIL”) whereby the
Company will seek to acquire the assets of Sequiam Corporation (‘Sequiam”). BIL
is Sequiam’s secured creditor. In connection with this transaction BIL has
agreed to provide no less than $6.0 million in new capital to the Company.
Crestview Capital Partners, the majority owner of BIL has agreed to be the
lead
investor in this new financing.
The
agreement is subject to BIL’s ability to secure the timely possession of
Sequiam’s assets and the lawful authority to transfer those assets to the
Company, free and clear of all liens.
A
copy of
the press release is attached as an Exhibit.
Item
9.01
Financial
Statements and Exhibits
c)
|
Exhibits |
|
|
|
99.1
Press
Release
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
|
|
|
BIOMETRX,
INC.
(Registrant)
|
|
|
|
Date:
March 24, 2008 |
By: |
/s/
Mark
Basile |
|
Mark
Basile |
|
Chief
Executive Officer |